REVOLAX™ SUB-Q with Lidocaine is provided as a sterile volume of 1.1 ml in a single-use glass syringe with two sterilized 25G mm needles. For REVOLAX™ Sub-Q Lidocaine, results will be effective for between 12 and 18 months.

REVOLAX™ Sub-Q with Lidocaine is frequently used to treat jawlines and correct noses. With just one wrinkle treatment, you can fill and sculpt chin and cheek areas and give your face a natural glow.

REVOLAX™ SUB-Q with Lidocaine is used for:

• Volumetry and face contouring
• Nose correction
• Cheek filling and modeling of cheekbones and chin
• Filling deep wrinkles
• HA concentration

REVOLAX™ SUB-Q with Lidocaine has the thickest properties within the product line. With its advanced ability to mould, maintain structure, and longevity – it is recommended for treatment of deep-sized to extremely severe wrinkles including nasolabial. This product also works best for cheek, chin, nose and jawline augmentation that requires a thicker substance to fill.

• REVOLAX™ Sub-Q with Lidocaine is recommended for intradermal implantation for volume loss and morphological asymmetry of the face.
• REVOLAX™ Sub-Q with Lidocaine works by reinforcing the weakened skin structure.
• Commence the treatment session by reviewing your patient’s medical information first to ensure that they are free from contraindicating conditions.
• Once patients are deemed suitable and they have been informed of the potential side effects, you can then obtain their consent for treatment.
• For the treatment itself, clean and disinfect the proposed treatment area(s).
• Next, inject REVOLAX™ Sub-Q with Lidocaine into the subcutaneous layer of the problematic skin region(s).
• Adhere to aseptic medical standards during the injection process to ensure a low risk of infections.

Contraindications:

• REVOLAX™ SUB-Q with Lidocaine should not be used in:
  • Pregnant or nursing women
  • Persons under 18 years of age
  • Patients known to be hypersensitive to hyaluronic acid.
  • Patients who tend to develop hypertrophic scars.
  • Immediately before or post laser therapy, chemical peeling or derma-brasion.
  • Areas presenting cutaneous inflammation or signs of infection.
• REVOLAX™ SUB-Q without Lidocaine should not be used in areas with inflammatory and infectious skin problems.

After-care:

• Do not use in patients with coagulation disorders or in patients who have been treated with thrombolytic anticoagulants or platelet aggregation inhibitors within the previous 2 weeks.
• Also, it is recommended to avoid taking aspirin, non-steroidal anti-inflammatory drugs or high doses of vitamin C the week before the injection.
• Patients are advised not to wear make-up for 12 hours after the injection and to avoid extended exposure to sunlight, UV light and extreme cold and heat for 2 weeks after the injection.